Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (71)

2024

  1. Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?

    Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315

  2. Immunoglobulin genes and severity of COVID-19

    Immunogenetics, Vol. 76, Núm. 3, pp. 213-217

  3. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

2023

  1. Age-dependent effect of the IFIH1/MDA5 gene variants on the risk of critical COVID-19

    Immunogenetics, Vol. 75, Núm. 2, pp. 91-98

  2. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  3. Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: safety, feasibility and diagnostic yield – experience in 50 cases

    ERJ Open Research, Vol. 9, Núm. 2

  4. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  5. Radiological Changes After Treatment With Triple Therapy in Cystic Fibrosis. Are Bronchiectasis Irreversible?

    Archivos de Bronconeumologia, Vol. 59, Núm. 2, pp. 118

  6. Respiratory Center Function and Its Impact in Obesity Hypoventilation Syndrome Treatment

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 497-501

  7. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. Bronchiectasis exacerbations: certainties and future challenges

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Vol. 26, Núm. 7, pp. 581-583

  3. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  4. FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19

    Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3589-3595

  5. Heart Failure with Reduced Ejection Fraction and Prognostic Scales: The Impact of Exercise Modality in Cardiopulmonary Exercise Tests

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  6. IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort

    Genes and Immunity, Vol. 23, Núm. 6, pp. 205-208

  7. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

  8. Results in clinical practice in the treatment of severe eosinophilic asthma with mepolizumab: a real-life study

    Journal of Asthma, Vol. 59, Núm. 5, pp. 1005-1011

  9. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  10. The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients

    Clinical Immunology, Vol. 236